Advancing 5-MeO-DMT
Through Partnership
We partner with educational institutions, research teams,
clinical trial teams, and policy initiatives to realize the full
scientific potential of 5-MeO-DMT, safely and responsibly.
Reviewed by The FIVE Institute · Last reviewed
Disclaimer: 5-MeO-DMT is a Schedule I controlled substance in the United States and is regulated in many jurisdictions. The FIVE Institute does not provide, sell, or source 5-MeO-DMT, and all partnerships operate within applicable law and research ethics approvals.
How Partnerships Drive Us Forward
Partnerships that help move 5-MeO-DMT
from evidence to safer standards of care.
The FIVE Institute partners with other educational institutions, research studies, clinical trial teams and policy initiatives to ensure the full therapeutic and scientific potential of 5-MeO-DMT is responsibly realized.
The FIVE Institute’s research partnerships span naturalistic and clinical studies conducted with institutional partners and extend into advisory support for clinical and pharmaceutical development. The expertise of leading researchers, clinicians, and legacy practitioners, paired with data and real-world evidence, drives new training, educational content, protocol design, and product development pathways, so the compound reaches the world safely and responsibly.
Research & Education Partners
We welcome research collaborations, education partnerships, and media inquiries related to 5-MeO-DMT.
In collaboration with academic institutions and research organizations, including Imperial College London and University College London (UCL), the Institute conducts naturalistic and clinical studies of 5-MeO-DMT and provides advisory support for clinical and pharmaceutical development.
The Institute also delivers harm reduction education to academic institutions, organizations, and companies in the psychedelic sector. Its work, together with that of its sister company, Tandava Retreats, has received coverage in leading international media.
Advisory for Drug Development
The FIVE Institute advises clinical and pharmaceutical development programs, grounded in real world evidence.
5-MeO-DMT
Research
Partnerships
From the world’s first EEG study to pharmaceutical advisory, trial design and more, collaboration is how the evidence keeps growing.
5-MeO-DMT
Educational
Partnerships
Educational material centralized around 5-MeO-DMT and harm reduction for clinicians, therapists and practitioners.
The FIVE Institute partners with academic institutions, organizations, and psychedelic companies to bring 5-MeO-DMT education and harm reduction resources to their audiences. Through live guest appearances, lectures, workshops, and prerecorded classes, we support clinicians, therapists, practitioners, and the wider community.
Formats: live guest appearances · lectures and panels · workshops · prerecorded classes
Partnership Inquiry
Tell us about your institution or program and how you would like to work together.
The FIVE Institute does not provide, sell, or source 5-MeO-DMT or any controlled substance.
We use your information only to respond to your inquiry. See our Privacy Policy.